Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ARCT Stock Forecast, Price Targets, Chart, Dividends & Analysis

Arcturus Therapeutics Ltd. logo

Arcturus Therapeutics Ltd.

Sector: Healthcare   

Industry: Biotechnology

15.48
 
USD
  
0.64
  
(4.31%)
Previous close: 14.84  Open: 14.7  Bid: 15.5  Ask: 16.0
52 week range    
14.30   
   45.00
Mkt Cap: 426 M  Avg Vol (90 Days): 401,431
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Monday 23rd December 2024

Stock Rankings

47
MarketXLS Rank
60
Value
30
Technical
52
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NWBO

NYMX

0.2

OHCS

OMIC

0 B-119.55
Financials

ARCT Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-2.15-3.55-7.740.35-1.12
Basic EPS total-2.15-3.55-7.740.35-1.12
Basic weighted shares outstanding12 M20 M26 M26 M27 M
Depreciation684000.0900000.01 M2 M3 M
DepreciationAndAmortization684000.0900000.01 M2 M3 M
Diluted EPS total-2.15-3.55-7.740.35-1.12
Diluted normalized net income/share0.35-1.12
Diluted weighted shares outstanding12 M20 M26 M27 M27 M
Earnings from equity interest-32000.0-263000.0515000.0-515000.0
EarningsFromEquityInterestNetOfTax-32000.0-263000.0515000.0-515000.0
GeneralAndAdministrativeExpense13 M23 M41 M46 M53 M
Gross operating profit21 M10 M12 M206 M167 M
Income before tax-26 M-72 M-204 M11 M-28 M
Income taxes1 M2 M
InterestExpenseNonOperating900000.0831000.03 M3 M767000.0
MiscOtherSpecialCharges-446000.0-361000.0-2 M-420000.051 M
Net income from total operations-26 M-72 M-204 M9 M-30 M
NetIncomeCommonStockholders-26 M-72 M-204 M9 M-30 M
NetIncomeContinuousOperations-26 M-72 M-204 M9 M-30 M
NetNonOperatingInterestIncomeExpense-900000.0-900000.0-800000.0420000.0-17 M
Normalized income-22 M
Operating income-26 M-72 M-203 M12 M-78 M
Operating income before depreciation (EBITDA)-24 M-70 M-202 M15 M-24 M
OperatingExpense46 M81 M215 M194 M236 M
Other income net478000.0624000.01 M-1 M34 M
OtherGandA13 M23 M41 M46 M53 M
OtherOperatingExpenses1 M-800000.0-1000000.0-1000000.0-600000.0
Research & development expense34 M58 M174 M148 M192 M
ResearchExpense34 M58 M174 M148 M192 M
Selling Gen & administrative expense13 M23 M41 M46 M53 M
Total Income available for interest expense (EBIT)-25 M-71 M-203 M14 M-27 M
Total common shares outstanding15 M26 M26 M27 M27 M
Total net income-26 M-72 M-204 M9 M-30 M
Total ordinary shares27 M27 M27 M27 M27 M
Total revenues21 M10 M12 M206 M167 M
TotalExpenses46 M81 M215 M194 M236 M
TotalRevenue21 M10 M12 M206 M158 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University